p38 gamma mitogen-activated protein kinase (p38γ MAPK (or MAPK12))

p38 gamma mitogen-activated protein kinase (p38γ MAPK, also known as MAPK12) is a member of the p38 MAPK family of serine/threonine kinases involved in transmitting extracellular signals into intracellular responses, particularly those triggered by environmental stress and inflammatory cytokines[6][7][3]. p38γ is encoded by the MAPK12 gene and is evolutionarily conserved. It is most abundantly expressed in skeletal muscle, where it regulates differentiation and regeneration by modulating MyoD activity and other muscle-specific genes[6][8]. While p38α is more broadly involved in inflammation, p38γ specifically modulates muscle cell fate and may play a role in certain cancers and inflammatory conditions. Unlike p38α/β, p38γ has unique substrate specificities and is less sensitive to conventional p38 MAPK inhibitors. It is a validated therapeutic target in research settings due to its roles in cell signaling, muscle biology, and disease[6][5][8].

Other names

MAPK12ERK6SAPK3Mitogen-activated protein kinase 12p38γp38 gamma

Kinase inhibition: Small molecules target the ATP-binding site to inhibit kinase activity, usually resulting in blockade of signal transduction for stress/inflammatory responses. Indirect modulation: Some drugs affect upstream regulators or signaling inputs rather than directly blocking p38γ.